Ets-1 expression and gemcitabine chemoresistance in pancreatic cancer cells

Gemcitabine, a novel pyrimidine nucleoside analog, has become the standard chemotherapeutic agent for pancreatic cancer patients. The clinical impact of gemcitabine remains modest owing to the high degree of inherent and acquired resistance. There are various lines of evidence that confirm the role...

Descripción completa

Detalles Bibliográficos
Autores principales: Khanna, Amit, Mahalingam, Kulandaivelu, Chakrabarti, Debarshi, Periyasamy, Giridharan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SP Versita 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6276009/
https://www.ncbi.nlm.nih.gov/pubmed/21225469
http://dx.doi.org/10.2478/s11658-010-0043-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6276009/
https://www.ncbi.nlm.nih.gov/pubmed/21225469
http://dx.doi.org/10.2478/s11658-010-0043-z

Ejemplares similares